Dissection of the immune landscape in psoriatic arthritis defines immunoproteasome up-regulation in treatment resistance
Science Immunology · 2025
DOI: 10.1126/sciimmunol.adu0284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2025. Verfasst von Reut Tzemach und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Proteasome Endopeptidase Complex, Drug Resistance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Despite substantial advancements in psoriatic arthritis (PsA) treatment modalities, a considerable proportion of patients continue to experience persistent joint inflammation, unresponsive to the armamentarium of disease-modifying antirheumatic drugs. Identifying previously unknown biomarkers and targets for refractory disease is urgently needed. Here, using single-cell RNA sequencing of synovial fluid from 41 patients with PsA and 9 osteoarthritis (OA) controls, we mapped the immune landscape of the pathogenic synovial fluid in patients with PsA. Our analysis revealed profound alterations in the myeloid compartment, primarily in type 2 conventional dendritic cells and monocytes. A comparison of these myeloid programs in PsA patient groups identified elevated expression of genes associated with the immunoproteasome and major histocompatibility complex class I as a major perturbation in refractory patients. Functional in vivo and in vitro experiments using a selective immunoproteasome inhibitor attenuated the activated myeloid compartment and disease manifestations. Our research imparts critical insights into PsA pathogenesis, potentially paving a way for targeted therapeutic interventions in treatment-resistant patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Department of Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Rheumatology Department, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv, Israel.
- Division of Orthopedic Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
ORCID-Profile: Reut Tzemach, Chamutal Gur, Truong San Phan, Mor Zada, Merav D Shmueli, Kfir Mazuz, Anna Kurilovich, Maya Ben Yehuda, Smadar Gertel, Tali Eviatar, Yifat Merbl, Daphna Paran, Shuang-Yin Wang, Ido Amit
Zitieren
APA
Tzemach, R., Gur, C., Phan, T. S., David, E., Zada, M., Shmueli, M. D., Mazuz, K., Sheban, F., Kurilovich, A., Yehuda, M. B., Furer, V., Polachek, A., Gertel, S., Snir, N., Eviatar, T., Nevo, S., Merbl, Y., Paran, D., Wang, S. Y., …, & Amit, I. (2025). Dissection of the immune landscape in psoriatic arthritis defines immunoproteasome up-regulation in treatment resistance. Science Immunology. https://doi.org/10.1126/sciimmunol.adu0284
Vancouver
Tzemach R, Gur C, Phan TS, David E, Zada M, Shmueli MD, et al. Dissection of the immune landscape in psoriatic arthritis defines immunoproteasome up-regulation in treatment resistance. Science Immunology. 2025. doi:10.1126/sciimmunol.adu0284
BibTeX
@article{Tzemach2025,
author = {Tzemach, Reut and Gur, Chamutal and Phan, Truong San and David, Eyal and Zada, Mor and Shmueli, Merav D and Mazuz, Kfir and Sheban, Fadi and Kurilovich, Anna and Yehuda, Maya Ben and Furer, Victoria and Polachek, Ari and Gertel, Smadar and Snir, Nimrod and Eviatar, Tali and Nevo, Sharon and Merbl, Yifat and Paran, Daphna and Wang, Shuang-Yin and Elkayam, Ori and Amit, Ido},
title = {Dissection of the immune landscape in psoriatic arthritis defines immunoproteasome up-regulation in treatment resistance},
journal = {Science Immunology},
year = {2025},
doi = {10.1126/sciimmunol.adu0284}
}
EUVIMED